← Open Payments lookup

MARK SCHREIBER: Open Payments

NPI 1124090022 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,747 in 98 payments from 15 companies in 2025. Trend: 2023 $2,289 · 2024 $1,739 · 2025 $1,747

Food & beverage: $1,747
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.22$496
ABBVIE INC.22$322
Otsuka America Pharmaceutical, Inc.13$200
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$156
Janssen Pharmaceuticals, Inc4$110
Neurocrine BioSciences, Inc.3$70
Vanda Pharmaceuticals Inc.4$67
Alkermes, Inc.3$62
Axsome Therapeutics, Inc.4$62
Takeda Pharmaceuticals U.S.A., Inc.3$50

Products named: COBENFY, VRAYLAR, CAPLYTA, REXULTI, INVEGA SUSTENNA, ABILIFY ASIMTUFII, INGREZZA, FANAPT.

Industry payments across VA — which companies pay providers there.